Literature DB >> 8426775

Individualized pharmacokinetic profiles to compute vancomycin dosage and dosing interval in preterm infants.

R V Jarrett1, G A Marinkovich, E L Gayle, J W Bass.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426775     DOI: 10.1097/00006454-199302000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  8 in total

Review 1.  Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.

Authors:  K A Rodvold; J A Everett; R D Pryka; D M Kraus
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 2.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

3.  Pharmacokinetics and dose requirements of vancomycin in neonates.

Authors:  C Grimsley; A H Thomson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

4.  Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.

Authors:  Erin Chung; Jonathan Sen; Priya Patel; Winnie Seto
Journal:  Clin Pharmacokinet       Date:  2021-05-18       Impact factor: 6.447

5.  Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation.

Authors:  Sook Hee An; Eun Mi Lee; Jae Yeon Kim; Hye Sun Gwak
Journal:  Eur J Hosp Pharm       Date:  2019-02-20

Review 6.  Vancomycin: pharmacokinetics and administration regimens in neonates.

Authors:  Matthijs de Hoog; Johan W Mouton; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Dose regimen for vancomycin not needing serum peak levels?

Authors:  W-H Tan; N Brown; A W Kelsall; R J McClure
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

Review 8.  Clinical pharmacokinetics of vancomycin in the neonate: a review.

Authors:  Gian Maria Pacifici; Karel Allegaert
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.